Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Milne

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Family Practice|December 30, 2008
The public health view on closing the gap between public health and primary careSusan Powell, Angela Towers, Paul Milne
Clinical Therapeutics|November 1, 2018
Regenerative Medicine at the Forefront of Innovation: Update From JapanChristopher-Paul Milne, Kenneth I Kaitin
Frontiers in Pharmacology|March 26, 2019
Are Regulation and Innovation Priorities Serving Public Health Needs?Christopher-Paul Milne, Kenneth I Kaitin
Clinical Therapeutics|July 15, 2018
Challenge and Change at the Forefront of Regenerative MedicineChristopher-Paul Milne, Kenneth I Kaitin
Quality in Primary Care|April 2, 2013
Improving the quality of primary carePaul Milne, Anne-Marie Coyne, David Pilgrim
American Journal of Therapeutics|December 23, 2009
Private sector contributions to pharmaceutical science: thirty-five summary case historiesBenjamin Zycher, Joseph A DiMasi, Christopher-Paul Milne
Nature Reviews. Drug Discovery|October 17, 2015
Market watch: Where is personalized medicine in industry heading?Christopher-Paul Milne, Joshua P Cohen, Ranjana Chakravarthy
Education for Primary Care : an Official Publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors|September 9, 2014
Reliability of non-pretested versus pretested questions in the applied knowledge test (AKT) of the MRCGP: evidence of quality assuranceHilton Dixon, Carol Blow, Paul Milne, et al.
Therapeutic Innovation & Regulatory Science|April 16, 2019
Impact of Regulatory Incentive Programs on the Future of Pediatric Drug DevelopmentElizabeth Yen, Jonathan M Davis, Christopher-Paul Milne
Personalized Medicine|May 12, 2018
State of the industry for drug-diagnostic development: challenge and change on the path to precision medicineChristopher-Paul Milne, Joshua Cohen, Ranjana Chakravarthy, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Family Practice|December 30, 2008
The public health view on closing the gap between public health and primary careSusan Powell, Angela Towers, Paul Milne
Clinical Therapeutics|November 1, 2018
Regenerative Medicine at the Forefront of Innovation: Update From JapanChristopher-Paul Milne, Kenneth I Kaitin
Frontiers in Pharmacology|March 26, 2019
Are Regulation and Innovation Priorities Serving Public Health Needs?Christopher-Paul Milne, Kenneth I Kaitin
Clinical Therapeutics|July 15, 2018
Challenge and Change at the Forefront of Regenerative MedicineChristopher-Paul Milne, Kenneth I Kaitin
Quality in Primary Care|April 2, 2013
Improving the quality of primary carePaul Milne, Anne-Marie Coyne, David Pilgrim
American Journal of Therapeutics|December 23, 2009
Private sector contributions to pharmaceutical science: thirty-five summary case historiesBenjamin Zycher, Joseph A DiMasi, Christopher-Paul Milne
Nature Reviews. Drug Discovery|October 17, 2015
Market watch: Where is personalized medicine in industry heading?Christopher-Paul Milne, Joshua P Cohen, Ranjana Chakravarthy
Education for Primary Care : an Official Publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors|September 9, 2014
Reliability of non-pretested versus pretested questions in the applied knowledge test (AKT) of the MRCGP: evidence of quality assuranceHilton Dixon, Carol Blow, Paul Milne, et al.
Therapeutic Innovation & Regulatory Science|April 16, 2019
Impact of Regulatory Incentive Programs on the Future of Pediatric Drug DevelopmentElizabeth Yen, Jonathan M Davis, Christopher-Paul Milne
Personalized Medicine|May 12, 2018
State of the industry for drug-diagnostic development: challenge and change on the path to precision medicineChristopher-Paul Milne, Joshua Cohen, Ranjana Chakravarthy, et al.
Pageof 7